Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Deracoxib Workflows for COX-2 and Canine Cancer
2026-08-12
Deracoxib connects selective COX-2 inhibition with practical workflows for canine pain, inflammation, and tumor-cell studies. Its value is greatest when concentration, exposure time, cell type, and apoptosis readouts are calibrated together rather than treated as interchangeable variables.
-
Cefazedone (Refosporen) in Cell Assays
2026-08-11
A scenario-driven guide to using Cefazedone (Refosporen), SKU BA1102, in antibacterial controls that accompany cell viability, proliferation, and cytotoxicity workflows. It separates bacterial MIC evidence from mammalian assay interpretation while covering formulation, storage, controls, and vendor-selection criteria.
-
Decitabine Workflow for Gastric Cancer Epigenetics
2026-08-11
Decitabine enables a practical test of whether DNA hypermethylation is driving tumor suppressor silencing rather than merely accompanying it. This workflow connects promoter methylation, HNF4A reactivation, epithelial polarity, EMT signaling, and immune-response assays in a controlled experimental sequence.
-
AP-2α Suppresses MGMT in Recurrent GBM
2026-08-10
This study identifies AP-2α as a transcriptional suppressor of MGMT in temozolomide-resistant recurrent glioma and connects its loss to impaired DNA damage and treatment resistance. It further shows that retinoic acid can activate the RAR/RXR–AP-2α pathway, providing a mechanistic framework for restoring temozolomide sensitivity in cellular and intracranial models.
-
Cholecystokinin octapeptide Ammonium: Cell Assays
2026-08-09
Cholecystokinin octapeptide ammonium enables receptor-aware workflows spanning LPS-activated B-cell assays, neuronal apoptosis studies, behavioral models, and ANP secretion research. This practical guide emphasizes sulfation-dependent activity, concentration scouting, fresh solution handling, and controls that distinguish CCK1R from CCK2R biology.
-
Puerarin Activates NO Signaling in Dental Follicle Cells
2026-08-08
The reference study identifies nitric oxide signaling as a mechanistic contributor to puerarin-induced osteogenic differentiation in rat dental follicle cells. By combining osteogenic markers with pharmacological NOS inhibition, it links puerarin treatment to the NO–cGMP–SGC/PKG-1 axis and provides a useful framework for periodontal regeneration research.
-
Calcium Channels in Cardiac Vagal Neuron Activation
2026-08-07
Wang, Irnaten, and Mendelowitz used whole-cell patch-clamp recordings and selective calcium-channel antagonists to show that nicotine activates cardiac vagal neurons through agatoxin-IVA-sensitive voltage-dependent calcium channels. The study separates presynaptic facilitation of glutamatergic release from the postsynaptic inward current, providing a pharmacological framework for analyzing nicotinic control of cardiac autonomic circuits.
-
Itraconazole: Triazole Antifungal Agent for Candida Biofilm
2026-08-07
Itraconazole (APExBIO SKU B2104) equips researchers with a potent, multi-mechanistic triazole antifungal agent for dissecting biofilm resistance and autophagy in pathogenic Candida. This guide delivers applied protocols, troubleshooting tips, and advanced insights on leveraging Itraconazole for robust, reproducible in vitro and in vivo antifungal workflows.
-
DAF-2 Diacetate: Precision Live-Cell Nitric Oxide Imaging Wo
2026-08-06
DAF-2 diacetate enables ultra-sensitive, quantitative detection of nitric oxide in live-cell, in vitro, and in vivo models. Its robust cell-permeable chemistry supports advanced NO signaling pathway studies, with proven success in dissecting plant nodule senescence and immune mechanisms.
-
Rapid Microwave Heating Preserves Lactoferrin Structure and
2026-08-06
This study demonstrates that the rapid heating rate of microwave (MW) processing, rather than dielectric effects, is key to preserving the structural integrity and bioactivity of lactoferrin during dairy pasteurization. These findings inform optimization of industrial MW pasteurization to maximize the retention of functional proteins in dairy products.
-
Cimetidine’s Distinct Role in H2R Signaling and High-Through
2026-08-05
Explore how Cimetidine, a histamine-2 receptor antagonist, uniquely advances research into H2 receptor signaling and blood-brain barrier models. This article offers a deep dive into its mechanistic advantages and how it redefines assay design in cancer and CNS drug discovery.
-
Cholecystokinin Octapeptide Antagonizes Electroacupuncture A
2026-08-05
This study reveals that cholecystokinin octapeptide (CCK-8) dose-dependently counteracts electroacupuncture (EA) analgesia in rats, implicating endogenous CCK-8 as a mediator of EA tolerance. The findings clarify the peptide's antagonistic role in opioid signaling pathways and provide a framework for exploring CCK-8's broader neuromodulatory functions.
-
Capsazepine: Advanced Insights into TRPV1 Antagonism and Pai
2026-08-04
Explore the unique role of Capsazepine as a TRPV1 ion channel antagonist in pain mechanism research. This article delivers an in-depth, comparative analysis of Capsazepine’s mechanistic utility and its advantages for translational studies on nociception and apoptosis.
-
Pam3CSK4 in Translational Immunology: Precision TLR1/2 Agoni
2026-08-04
Explore how Pam3CSK4, a potent TLR1/2 agonist, is advancing translational immunology by enabling targeted immune cell activation and nuanced control of inflammatory responses. This article uniquely examines the intersection of TLR signaling, neuro-immune modulation, and experimental design, offering insights beyond existing guides.
-
2-NBDG in Glucose Metabolism Assays: Protocols & Innovations
2026-08-03
Harnessing 2-NBDG enables high-sensitivity, real-time analysis of cellular glucose uptake across cancer, metabolic disease, and neuroscience models. This guide integrates the latest protocol enhancements and troubleshooting strategies—rooted in leading research and practical lab experience—to elevate your glucose metabolism studies.